Abstract
ObjectiveAntitumour necrosis factor (TNF) drugs impair serological responses following SARS-CoV-2 vaccination. We sought to assess if a third dose of a messenger RNA (mRNA)-based vaccine substantially boosted anti-SARS-CoV-2 antibody responses...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have